No Data
Jieya Co., Ltd. (301108.SZ): Invested in the establishment of a wholly-owned subsidiary in the usa and completed the business registration.
On November 21, Gelonghui reported that Jeya Co., Ltd. (301108.SZ) announced the establishment of a wholly-owned subsidiary, Joyalways Investment Corporation (hereinafter referred to as "USA Subsidiary"), in Delaware, USA, with its own funds to meet the business development needs of the company, deepen cooperation with overseas customers, and improve the stability and efficiency of the international supply chain, in line with the company's actual situation. The main business of the USA Subsidiary will be to engage in import and export trade and serve as an investment platform for overseas investment activities. Recently, the company received the registration certificate for the USA Subsidiary.
Tongling Jieya Biologic Technology's (SZSE:301108) Anemic Earnings Might Be Worse Than You Think
Clean Elegant Co., Ltd. (301108.SZ): The main growth points of future profits mainly depend on the expansion of existing business and new product categories for existing customers.
Gelonghui, October 31 - Jiaya Stock (301108.SZ) received a specific research inquiry on October 31, 2024, regarding "What are the future profit growth points of the company?" The company stated that it mainly relies on expanding the existing customer base and developing new product categories. With the introduction of the EU's plastic limit policy, some international brands are relocating their supply chains, and the company is actively engaging in discussions to undertake relevant business.
Jieya Co., Ltd.: Report for the third quarter of 2024
Jieya Corporation (301108.SZ) released its performance for the first three quarters, with a net income of 34.6837 million yuan, a decrease of 62.94%.
Elegant Group (301108.SZ) released the third quarter report of 2024, the company's revenue for the first three quarters was 4...
Jieya Co., Ltd. (301108.SZ): The net income in the first three quarters was 34.6837 million yuan, a year-on-year decrease of 62.94%.
On October 29, Gelonhui announced the third quarter report of 2024. In the first three quarters of 2024, the company achieved revenue of 0.408 billion yuan, a decrease of 8.79% year-on-year; the net income attributable to shareholders of the listed company was 34.6837 million yuan, a decrease of 62.94% year-on-year; the net income after deducting non-recurring gains and losses was 21.8502 million yuan, a decrease of 70.82% year-on-year; the basic earnings per share was 0.43 yuan per share.
Returns On Capital Signal Tricky Times Ahead For Tongling Jieya Biologic Technology (SZSE:301108)No Data
No Data
